What is the treatment for Yersinia (Y) pestis infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Yersinia pestis Infection

The most effective treatment for Yersinia pestis infection is dual antimicrobial therapy with a fluoroquinolone (ciprofloxacin, levofloxacin, or moxifloxacin) plus an aminoglycoside (gentamicin or streptomycin) for 10-14 days, which significantly reduces mortality across all clinical forms of plague. 1

First-Line Treatment Options

Recommended Dual Therapy

  • Fluoroquinolone + Aminoglycoside combination:

    • Ciprofloxacin (400 mg IV every 8 hours or 750 mg PO every 12 hours) plus
    • Gentamicin (5 mg/kg IV/IM every 24 hours) or
    • Streptomycin (15 mg/kg IM every 12 hours, maximum 1 g/dose) 1
  • Alternative fluoroquinolones:

    • Levofloxacin (750 mg IV/PO every 24 hours) 2
    • Moxifloxacin (400 mg IV/PO every 24 hours) 3

Treatment Duration

  • Continue treatment for 10-14 days or until the patient has been afebrile for at least 48 hours 1
  • Early initiation of therapy is critical as mortality rates can reach 50% without treatment but decrease to 5-10% with timely treatment 1

Treatment Based on Clinical Form

Bubonic Plague

  • Dual therapy as outlined above
  • Place patient in respiratory isolation for the first 48 hours of effective treatment to prevent secondary transmission of pneumonic plague 1
  • Monitor for clinical improvement within 24-48 hours 1

Pneumonic or Septicemic Plague

  • Immediate initiation of dual therapy is critical
  • Strict respiratory isolation for 48 hours after starting effective therapy 1
  • More aggressive supportive care may be needed due to higher mortality rates

Special Populations

Pregnant Women

  • Fluoroquinolones remain first-line despite pregnancy
  • Gentamicin is an acceptable alternative but requires monitoring 1

Children

  • Same first-line agents as adults with adjusted dosing
  • Doxycycline should only be used in children <8 years when other options are unavailable due to dental staining risk 1

Bioterrorism Considerations

  • In the event of a bioterrorism attack using a strain of Y. pestis engineered for resistance, dual therapy with distinct classes of antimicrobials is strongly recommended 4
  • Levofloxacin and moxifloxacin have demonstrated efficacy in animal models of pneumonic plague, which supports their use in bioterrorism scenarios 2, 3

Monitoring and Adjustments

  • Monitor patients for clinical improvement within 24-48 hours
  • Check aminoglycoside levels as indicated to prevent toxicity
  • Adjust therapy based on culture and sensitivity results when available 1
  • Be aware that intracellular Y. pestis may be less susceptible to certain antibiotics like gentamicin or doxycycline, while streptomycin and ciprofloxacin maintain similar efficacy against both intracellular and extracellular bacteria 5

Common Pitfalls to Avoid

  • Delayed treatment initiation (treatment should begin within 24 hours of symptom onset)
  • Using monotherapy in severe cases or suspected bioterrorism
  • Inadequate duration of treatment
  • Failure to consider plague in differential diagnosis
  • Improper isolation procedures
  • Using beta-lactam antibiotics as monotherapy due to potential poor efficacy 1

Post-Exposure Prophylaxis

  • For individuals exposed to Y. pestis, post-exposure prophylaxis with ciprofloxacin, levofloxacin, or doxycycline for 7 days is recommended 1

References

Guideline

Treatment of Plague

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.